Approval · Notice of Compliance 1443 · 2000
PMS-RANITIDINE: Notice of Compliance 1443
Issued August 9, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1443
- Date
- August 9, 2000
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Histamine H2-receptor antagonist
- Canadian reference product
- ZANTAC (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-RANITIDINE | 02242453 | Cancelled Post Market |
| PMS-RANITIDINE | 02242454 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB